Tuesday, Apr 22 2025 | Time 12:10 Hrs(IST)
Business EconomyPosted at: Apr 18 2025 3:16PM


Zydus Medtech partners with Braile Biomedica to commercialise TAVI technology

Mumbai, Apr 18 (UNI) Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited on Friday entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda., (Braile Biomedica) - an innovative cardiovascular device manufacturer based in Brazil - to exclusively commercialise its Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other select markets.

It was a significant step in Zydus MedTech’s strategic expansion into the fast-growing interventional cardiology segment.
Dr Sharvil Patel, Managing Director of Zydus Lifesciences Ltd., said “We stand united with Braile to improve patient outcomes and expand access to advanced, critical cardiovascular care globally. This innovative, cutting-edge technology will offer a minimally invasive approach that also supports faster recovery, reduced hospital stays, and greatly improved quality of life for patients.”
The global TAVI market, currently valued at over USD 6 billion, continues to witness strong growth driven by the increasing incidence of aortic stenosis and the rising demand for minimally invasive cardiac procedures.
Zydus MedTech, which is actively building its interventional cardiology portfolio, will introduce Braile Biomedica’s advanced balloon-expandable TAVI system to international markets, leveraging its commercial and regulatory expertise. Braile Biomedica - with a proven track record in cardiovascular innovation, particularly in Latin America - will manufacture and supply the product for these markets.
This agreement aligns with both companies’ shared commitment to delivering life-saving technologies to a broader patient population. The TAVI procedure is a recognized breakthrough in structural heart care, particularly for elderly patients or those at high surgical risk. By replacing the diseased aortic valve through a catheter-based approach - without the need for open-heart surgery - patients often experience significantly shorter recovery times and reduced procedural risks. The expansion of TAVI indications to all-risk patients has further accelerated its adoption.
UNI JS NV CS
Please log in to get detailed story.
Tags: #Zydus Medtech partners with Braile Biomedica to commercialise TAVI technology
More News
Sensex up over 200 pts

Sensex up over 200 pts

22 Apr 2025 | 10:13 AM

Mumbai, Apr 22 (UNI) The BSE Sensex remained firm for the sixth straight session on Tuesday, rising 205 pts at 79,614.40 in opening session as buying was seen across the board amid consistent inflow from foreign investors.

see more..
Airtel announces new features in its continued fight against SPAM

Airtel announces new features in its continued fight against SPAM

21 Apr 2025 | 9:50 PM

Kolkata, Apr 21 (UNI) Following the launch of its AI powered spam detection tool that flagged over 27.5 billion calls as SPAM to its customers, telecom operator Airtel on Monday announced the introduction of two significant enhancements aimed at staying ahead of spammers.

see more..

ParamNetwork launches India’s 1st enterprise-grade Agentic AI platform

21 Apr 2025 | 7:12 PM

Pune, Apr 21 (UNI) ParamNetwork on Monday announced the global launch of (param) ai/studio, India’s first enterprise-grade Agentic AI platform, designed to meet the complex requirements of modern enterprises.

see more..

Tally Solutions launches TallyPrime 6 0, Revolutionizing financial ops for SMEs with connected banking

21 Apr 2025 | 7:06 PM

Kolkata, Apr 21 (UNI) Tally Solutions Pvt Ltd, India’s leading business automation software provider, has introduces its latest release, TallyPrime 6.0, designed to simplify financial operations for small and medium enterprises (SMEs) and make it seamless via Connected Banking experience.

see more..

JSW Energy breaks ground on 1600 MW ultra supercritical thermal power plant at Salboni in Bengal

21 Apr 2025 | 6:56 PM

Kolkata, Apr 21 (UNI) JSW Energy Limited, a leading private-sector power producer in India and a part of the $24 Billion JSW Group, on Monday commenced construction of its state-of-the-art 1,600 MW (2x800 MW) ultra supercritical thermal power plant in Salboni, West Bengal.

see more..